Lv11
21 积分 2021-11-02 加入
BCL6 confers resistance to HDAC inhibitors in DLBCL
5小时前
已完结
Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo
5小时前
已完结
Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor
2天前
已完结
Activation of the GLP-1 receptor by a non-peptidic agonist
4天前
已完结
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2– Breast Cancer
7天前
已完结
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer
7天前
已完结
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)
8天前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
8天前
已完结
Heterobifunctional Protein Binders Enable Cell Type-Specific Killing Through In-cell Enrichment
13天前
已完结
Discovery of KDX1381, a Bivalent CK2α Inhibitor for the Treatment of Solid Tumors as a Single Agent or in Combination
18天前
已完结
皖公网安备34019202002308
